The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of clofarabine and daunorubicin in patients age 60 or older with newly diagnosed adult acute myeloid leukemia.
Carlos Enrique Vigil
Research Funding - Genzyme
Elizabeth A. Griffiths
No relevant relationships to disclose
James E Thompson
No relevant relationships to disclose
Wei Tan
No relevant relationships to disclose
Jessica Greene
No relevant relationships to disclose
Laurie Ann Ford
No relevant relationships to disclose
Eunice S. Wang
No relevant relationships to disclose
Meir Wetzler
Research Funding - Genzyme